72 Investment Holdings’s LENZ Therapeutics LENZ Stock Holding History

72 Investment Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.78M	Hold	1,017,751	–	–	11.57%	3
2026 Q1	$9.31M	Hold	1,017,751	–	–	18.77%	3
2025 Q4	$16.3M	Hold	1,017,751	–	–	32.2%	2
2025 Q3	$47.4M	Hold	1,017,751	–	–	69.77%	1
2025 Q2	$29.8M	Hold	1,017,751	–	–	77.84%	1
2025 Q1	$26.2M	Hold	1,017,751	–	–	73.53%	1
2024 Q4	$29.4M	Hold	1,017,751	–	–	59.83%	1
2024 Q3	$24.2M	Hold	1,017,751	–	–	51.95%	1
2024 Q2	$17.6M	Hold	1,017,751	–	–	44.23%	1
2024 Q1	$22.7M	Buy	+1,017,751	New	+$21.2M	33.88%	2

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

72 Investment Holdings's LENZ Position: Q2 2026 in Review

72 Investment Holdings held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 1,017,751 shares worth $5.78M. The position accounts for 11.57% of the portfolio, ranked #3.

72 Investment Holdings first reported a position in LENZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $47.4M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

72 Investment Holdings held 1,017,751 shares of LENZ Therapeutics worth $5.78M as of Q2 2026.
72 Investment Holdings left its LENZ Therapeutics share count unchanged in Q2 2026.
LENZ Therapeutics made up 11.57% of 72 Investment Holdings's portfolio in Q2 2026, its #3 holding.
72 Investment Holdings first reported a position in LENZ Therapeutics in Q1 2024 and has held it in 10 quarters since.
72 Investment Holdings's LENZ Therapeutics position peaked at $47.4M in Q3 2025.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on 72 Investment Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.